Cargando…

The role of perivascular adipose tissue in obesity‐induced vascular dysfunction

Under physiological conditions, perivascular adipose tissue (PVAT) attenuates agonist‐induced vasoconstriction by releasing vasoactive molecules including hydrogen peroxide, angiotensin 1–7, adiponectin, methyl palmitate, hydrogen sulfide, NO and leptin. This anticontractile effect of PVAT is lost u...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Ning, Li, Huige
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610151/
https://www.ncbi.nlm.nih.gov/pubmed/27761903
http://dx.doi.org/10.1111/bph.13650
_version_ 1783265723541356544
author Xia, Ning
Li, Huige
author_facet Xia, Ning
Li, Huige
author_sort Xia, Ning
collection PubMed
description Under physiological conditions, perivascular adipose tissue (PVAT) attenuates agonist‐induced vasoconstriction by releasing vasoactive molecules including hydrogen peroxide, angiotensin 1–7, adiponectin, methyl palmitate, hydrogen sulfide, NO and leptin. This anticontractile effect of PVAT is lost under conditions of obesity. The central mechanism underlying this PVAT dysfunction in obesity is likely to be an ‘obesity triad’ (consisting of PVAT hypoxia, inflammation and oxidative stress) that leads to the impairment of PVAT‐derived vasoregulators. The production of hydrogen sulfide, NO and adiponectin by PVAT is reduced in obesity, whereas the vasodilator response to leptin is impaired (vascular leptin resistance). Strikingly, the vasodilator response to acetylcholine is reduced only in PVAT‐containing, but not in PVAT‐free thoracic aorta isolated from diet‐induced obese mice, indicating a unique role for PVAT in obesity‐induced vascular dysfunction. Furthermore, PVAT dysfunction has also been observed in small arteries isolated from the gluteal/visceral fat biopsy samples of obese individuals. Therefore, PVAT may represent a new therapeutic target for vascular complications in obesity. A number of approaches are currently being tested under experimental conditions. Potential therapeutic strategies improving PVAT function include body weight reduction, enhancing PVAT hydrogen sulfide release (e.g. rosiglitazone, atorvastatin and cannabinoid CB(1) receptor agonists) and NO production (e.g. arginase inhibitors), inhibition of the renin–angiotensin–aldosterone system, inhibition of inflammation with melatonin or cytokine antagonists, activators of AMP‐activated kinase (e.g. metformin, resveratrol and diosgenin) and adiponectin releasers or expression enhancers. LINKED ARTICLES: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue – Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc
format Online
Article
Text
id pubmed-5610151
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56101512017-09-25 The role of perivascular adipose tissue in obesity‐induced vascular dysfunction Xia, Ning Li, Huige Br J Pharmacol Themed Section: Review Articles Under physiological conditions, perivascular adipose tissue (PVAT) attenuates agonist‐induced vasoconstriction by releasing vasoactive molecules including hydrogen peroxide, angiotensin 1–7, adiponectin, methyl palmitate, hydrogen sulfide, NO and leptin. This anticontractile effect of PVAT is lost under conditions of obesity. The central mechanism underlying this PVAT dysfunction in obesity is likely to be an ‘obesity triad’ (consisting of PVAT hypoxia, inflammation and oxidative stress) that leads to the impairment of PVAT‐derived vasoregulators. The production of hydrogen sulfide, NO and adiponectin by PVAT is reduced in obesity, whereas the vasodilator response to leptin is impaired (vascular leptin resistance). Strikingly, the vasodilator response to acetylcholine is reduced only in PVAT‐containing, but not in PVAT‐free thoracic aorta isolated from diet‐induced obese mice, indicating a unique role for PVAT in obesity‐induced vascular dysfunction. Furthermore, PVAT dysfunction has also been observed in small arteries isolated from the gluteal/visceral fat biopsy samples of obese individuals. Therefore, PVAT may represent a new therapeutic target for vascular complications in obesity. A number of approaches are currently being tested under experimental conditions. Potential therapeutic strategies improving PVAT function include body weight reduction, enhancing PVAT hydrogen sulfide release (e.g. rosiglitazone, atorvastatin and cannabinoid CB(1) receptor agonists) and NO production (e.g. arginase inhibitors), inhibition of the renin–angiotensin–aldosterone system, inhibition of inflammation with melatonin or cytokine antagonists, activators of AMP‐activated kinase (e.g. metformin, resveratrol and diosgenin) and adiponectin releasers or expression enhancers. LINKED ARTICLES: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue – Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc John Wiley and Sons Inc. 2016-11-17 2017-10 /pmc/articles/PMC5610151/ /pubmed/27761903 http://dx.doi.org/10.1111/bph.13650 Text en © 2016 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Themed Section: Review Articles
Xia, Ning
Li, Huige
The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
title The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
title_full The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
title_fullStr The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
title_full_unstemmed The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
title_short The role of perivascular adipose tissue in obesity‐induced vascular dysfunction
title_sort role of perivascular adipose tissue in obesity‐induced vascular dysfunction
topic Themed Section: Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610151/
https://www.ncbi.nlm.nih.gov/pubmed/27761903
http://dx.doi.org/10.1111/bph.13650
work_keys_str_mv AT xianing theroleofperivascularadiposetissueinobesityinducedvasculardysfunction
AT lihuige theroleofperivascularadiposetissueinobesityinducedvasculardysfunction
AT xianing roleofperivascularadiposetissueinobesityinducedvasculardysfunction
AT lihuige roleofperivascularadiposetissueinobesityinducedvasculardysfunction